GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the Audited Standalone and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
GKB Ophthalmics Ltd has notified BSE that a Board meeting is scheduled for May 27, 2026 at its registered office in Goa. The meeting will consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The company has also updated its trading window closure - the insider trading prohibition window, which was closed from April 1, 2026, will reopen after 48 hours from the submission of financial results to the stock exchange. This is a standard quarterly results approval meeting as required under SEBI listing regulations.
This is a routine meeting notice and does not contain any financial data or results. Shareholders should await the actual financial results announcement after May 27, 2026 for insights into company performance.